Literature DB >> 21809138

The roles of thrombin and protease-activated receptors in inflammation.

Liang Ma1, Anthony Dorling.   

Abstract

Inflammation and coagulation constitute two host defence systems with complementary physiological roles in limiting tissue damage, restoring homeostasis and eliminating invading pathogens, functions reliant on effective regulation of both processes at a variety of levels. Dysfunctional activation or regulation of either pathway may lead to pathology and contribute to human diseases as diverse as myocardial infarction and septic shock. The serine protease thrombin, a key protein in the coagulation pathway, can activate cellular signalling directly via proteolytic cleavage of the N-terminal domain of a family of G protein-coupled receptors or indirectly through the generation of molecules such as activated protein C. These events transmit signals to many cell types and can elicit the production of various pro-inflammatory mediators such as cytokines, chemokines and growth factors, thereby influencing cell activation, differentiation, survival and migration. This review discusses recent progress in understanding how thrombin and protease-activated receptors influence biological processes, highlighting the detrimental and protective cellular effects of thrombin and its signalling pathways.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21809138     DOI: 10.1007/s00281-011-0281-9

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  75 in total

Review 1.  The cytoprotective protein C pathway.

Authors:  Laurent O Mosnier; Berislav V Zlokovic; John H Griffin
Journal:  Blood       Date:  2006-11-16       Impact factor: 22.113

2.  Release of gelatinase A during platelet activation mediates aggregation.

Authors:  G Sawicki; E Salas; J Murat; H Miszta-Lane; M W Radomski
Journal:  Nature       Date:  1997-04-10       Impact factor: 49.962

3.  Transactivation of sphingosine 1-phosphate receptors is essential for vascular barrier regulation. Novel role for hyaluronan and CD44 receptor family.

Authors:  Patrick A Singleton; Steven M Dudek; Shwu-Fan Ma; Joe G N Garcia
Journal:  J Biol Chem       Date:  2006-09-08       Impact factor: 5.157

4.  Human cytomegalovirus increases HUVEC sensitivity to thrombin and modulates expression of thrombin receptors.

Authors:  Milan Popović; Svetlana Paskas; Maja Zivković; Ladislav Burysek; Yves Laumonnier
Journal:  J Thromb Thrombolysis       Date:  2010-08       Impact factor: 2.300

Review 5.  Inflammation and the activated protein C anticoagulant pathway.

Authors:  Charles T Esmon
Journal:  Semin Thromb Hemost       Date:  2006-04       Impact factor: 4.180

6.  Proteinase-activated receptors-1 and 2 induce electrogenic Cl- secretion in the mouse cecum by distinct mechanisms.

Authors:  Osamu Ikehara; Hisayoshi Hayashi; Yuko Watanabe; Hiroyuki Yamamoto; Tohru Mochizuki; Minoru Hoshino; Yuichi Suzuki
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-04-22       Impact factor: 4.052

Review 7.  Thrombin and phenotypic modulation of the endothelium.

Authors:  Takashi Minami; Akira Sugiyama; Sheng-Qian Wu; Ruhul Abid; Tatsuhiko Kodama; William C Aird
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-10-09       Impact factor: 8.311

8.  Proteinase-activated receptor-4 (PAR4) activation leads to sensitization of rat joint primary afferents via a bradykinin B2 receptor-dependent mechanism.

Authors:  Fiona A Russell; Victoria E Veldhoen; Dmitri Tchitchkan; Jason J McDougall
Journal:  J Neurophysiol       Date:  2009-11-04       Impact factor: 2.714

9.  Analysis of proteinase-activated receptor 2 and TLR4 signal transduction: a novel paradigm for receptor cooperativity.

Authors:  Prasad Rallabhandi; Quan M Nhu; Vladimir Y Toshchakov; Wenji Piao; Andrei E Medvedev; Morley D Hollenberg; Alessio Fasano; Stefanie N Vogel
Journal:  J Biol Chem       Date:  2008-07-11       Impact factor: 5.157

10.  Platelet matrix metalloprotease-1 mediates thrombogenesis by activating PAR1 at a cryptic ligand site.

Authors:  Vishal Trivedi; Adrienne Boire; Boris Tchernychev; Nicole C Kaneider; Andrew J Leger; Katie O'Callaghan; Lidija Covic; Athan Kuliopulos
Journal:  Cell       Date:  2009-04-17       Impact factor: 41.582

View more
  29 in total

1.  Serum analysis of coagulation factors in IPF and NSIP.

Authors:  E Bargagli; C Madioni; N Bianchi; R M Refini; R Cappelli; P Rottoli
Journal:  Inflammation       Date:  2014-02       Impact factor: 4.092

Review 2.  The intertwined fates of inflammation and coagulation in glioma.

Authors:  Angela Cho; Kelly J McKelvey; Adrian Lee; Amanda L Hudson
Journal:  Mamm Genome       Date:  2018-07-30       Impact factor: 2.957

Review 3.  Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases.

Authors:  Elizabeth A Middleton; Andrew S Weyrich; Guy A Zimmerman
Journal:  Physiol Rev       Date:  2016-08-03       Impact factor: 37.312

4.  Thrombin drives tumorigenesis in colitis-associated colon cancer.

Authors:  Brian Turpin; Whitney Miller; Leah Rosenfeldt; Keith Kombrinck; Matthew J Flick; Kris A Steinbrecher; Eleana Harmel-Laws; Eric S Mullins; Maureen Shaw; David P Witte; Alexey Revenko; Brett Monia; Joseph S Palumbo
Journal:  Cancer Res       Date:  2014-04-07       Impact factor: 12.701

Review 5.  Physical Exercise as a Modulator of Vascular Pathology and Thrombin Generation to Improve Outcomes After Traumatic Brain Injury.

Authors:  Willian Link Papalia; Alexandre Seixas Nascimento; Gokul Krishna; Núbia Broetto; Ana Flavia Furian; Mauro Schneider Oliveira; Luiz Fernando Freire Royes; Michele Rechia Fighera
Journal:  Mol Neurobiol       Date:  2021-11-30       Impact factor: 5.590

Review 6.  Platelets as cellular effectors of inflammation in vascular diseases.

Authors:  Matthew T Rondina; Andrew S Weyrich; Guy A Zimmerman
Journal:  Circ Res       Date:  2013-05-24       Impact factor: 17.367

7.  Experimental hypercoagulable state induced by tissue factor expression in monocyte-derived dendritic cells and its modulation by C1 inhibitor.

Authors:  Shogo Kasuda; Yoshihiko Sakurai; Kohei Tatsumi; Tomohiro Takeda; Risa Kudo; Katsuya Yuui; Katsuhiko Hatake
Journal:  J Thromb Thrombolysis       Date:  2018-08       Impact factor: 2.300

Review 8.  Thrombin generation and atherosclerosis.

Authors:  Jana Kalz; Hugo ten Cate; Henri M H Spronk
Journal:  J Thromb Thrombolysis       Date:  2014-01       Impact factor: 2.300

9.  Dabigatran mitigates cisplatin-mediated nephrotoxicity through down regulation of thrombin pathway.

Authors:  Mohamed Gamal El-Din Ewees; Mohamed Sadek Abdel-Bakky; Asmaa Mostafa Ahmed Bayoumi; Ali Ahmed Abo-Saif; Waleed Mohammad Altowayan; Khalid Saad Alharbi; Basim Anwar Shehata Messiha
Journal:  J Adv Res       Date:  2021-01-05       Impact factor: 10.479

10.  Proteinase-activated receptor-1, CCL2, and CCL7 regulate acute neutrophilic lung inflammation.

Authors:  Paul F Mercer; Andrew E Williams; Christopher J Scotton; Ricardo J José; Michal Sulikowski; James D Moffatt; Lynne A Murray; Rachel C Chambers
Journal:  Am J Respir Cell Mol Biol       Date:  2014-01       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.